| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Allophycocyanin | IC18341A | |||
| PerCP (Peridinin-chlorophyll Protein Complex) | IC18341C | |||
| Phycoerythrin | IC18341P | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | IC18341C | |||
| Carrier Free | IC18341P | |||
| Carrier Free | IC18341A | |||
| Carrier Free | MAB18341-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | IC6456A | |||
| Carrier Free | IC6456G | |||
| Carrier Free | MAB6456-SP | |||
| Carrier Free | IC6456N-100UG | |||
| Carrier Free | IC6456V-100UG | |||
| Carrier Free | IC6456U-100UG | |||
| Carrier Free | IC6456T-100UG | |||
| Carrier Free | IC6456S-100UG | |||
| Carrier Free | IC6456R-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB64561-SP | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| PerCP (Peridinin-chlorophyll Protein Complex) | IC18341C | |||
| Phycoerythrin | IC18341P | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | IC18341C | |||
| Carrier Free | IC18341P | |||
| Carrier Free | MAB18341 | |||
| Carrier Free | MAB18341-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide Free | NBP2-27363 | |||
| BSA Free | NBP2-27362SS | |||
| Azide Free | NBP2-27363-0.5mg | |||
| Azide Free | NBP2-27363-1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-03944SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76976-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-80709 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-80706 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-80710 | |||
![Western Blot: EBI3 Antibody (15k8D10) [NBP2-27362] - Analysis of IL-35-Fc protein (A) and human Fc (B) using IL-35 antibody at 4ug/ml.](http://images.novusbio.com/fullsize/EBI3-Antibody-15k8D10-Tissue-Culture-Substratum-NBP2-27362-img0001.jpg "Western Blot: EBI3 Antibody (15k8D10) [NBP2-27362] - Analysis of IL-35-Fc protein (A) and human Fc (B) using IL-35 antibody at 4ug/ml.")
![Immunohistochemistry-Paraffin: EBI3 Antibody (15k8D10) [NBP2-27362] - Formalin-fixed, paraffin-embedded human spleen (left) and lymph node metastatic malignant melanoma (right) stained with IL-35 antibody (5 ug/ml) using peroxidase-conjugate and DAB chromogen.](http://images.novusbio.com/fullsize/EBI3-Antibody-15k8D10-Immunohistochemistry-Paraffin-NBP2-27362-img0002.jpg)
![Western Blot: IL-27/IL-35 EBI3 Subunit Antibody [NBP2-03944] - Total protein from human HeLa, K562 and mouse Raw264.7 cells was separated on a 4-20% gel by SDS-PAGE, transferred to PVDF membrane and blocked in 5% non-fat milk in TBST. The membrane was probed with 2.0 ug/ml anti-EBI3 in 1% non-fat milk in TBST and detected with an anti-rabbit HRP secondary antibody using chemiluminescence.](http://images.novusbio.com/fullsize/IL-27-IL-35-EBI3-Subunit-Antibody-Western-Blot-NBP2-03944-img0009.jpg "Western Blot: IL-27/IL-35 EBI3 Subunit Antibody [NBP2-03944] - Total protein from human HeLa, K562 and mouse Raw264.7 cells was separated on a 4-20% gel by SDS-PAGE, transferred to PVDF membrane and blocked in 5% non-fat milk in TBST. The membrane was probed with 2.0 ug/ml anti-EBI3 in 1% non-fat milk in TBST and detected with an anti-rabbit HRP secondary antibody using chemiluminescence.")
![Immunohistochemistry-Paraffin: IL-27/IL-35 EBI3 Subunit Antibody [NBP2-03944] - Mouse brain tissue stained with EBI3 antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/IL-27-IL-35-EBI3-Subunit-Antibody-Immunohistochemistry-Paraffin-NBP2-03944-img0008.jpg)
![Immunohistochemistry-Paraffin: IL-27/IL-35 EBI3 Subunit Antibody [NBP2-03944] - Mouse brain tissue using an isotype control (top left) and (bottom left, right) at 5 ug/ml.](http://images.novusbio.com/fullsize/IL-27-IL-35-EBI3-Subunit-Antibody-Immunohistochemistry-Paraffin-NBP2-03944-img0007.jpg)
![Western Blot: EBI3 Antibody [NBP1-76976] - Analysis of EBI3 in human tonsil tissue lysate with EBI3 antibody at 2 ug/mL.](http://images.novusbio.com/fullsize/EBI3-Antibody-Western-Blot-NBP1-76976-img0007.jpg "Western Blot: EBI3 Antibody [NBP1-76976] - Analysis of EBI3 in human tonsil tissue lysate with EBI3 antibody at 2 ug/mL.")
![Western Blot: EBI3 Antibody [NBP1-76976] - K562 lysate with EBI3 antibody at 1 ug/ml in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/EBI3-Antibody-Western-Blot-NBP1-76976-img0005.jpg)
![Western Blot: EBI3 Antibody - BSA Free [NBP1-76976] - Recombinant Protein Validation. Loading: 30 ng of human recombinant IL-17 (IL-17A+IL-17B) protein per lane.Antibodies: EBI-3 , 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.Lane 1: 1 ug/mL, Lane 2: 2 ug/mL, Lane 3: 4 ug/mL,](http://images.novusbio.com/fullsize/nbp1-76976_rabbit-polyclonal-ebi3-antibody-271120242016957.gif)
![Immunohistochemistry: EBI3 Antibody - BSA Free [NBP1-76976] - Validation of EBI-3 in Human Spleen Tissue. Immunohistochemical analysis of paraffin-embedded Human Spleen tissue using anti-EBI-3 antibody at 2.5 ug/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.](http://images.novusbio.com/fullsize/nbp1-76976_rabbit-polyclonal-ebi3-antibody-2711202419475868.jpg)
![Immunocytochemistry/ Immunofluorescence: EBI3 Antibody - BSA Free [NBP1-76976] - Validation of EBI-3 in Human Spleen Tissue. Immunofluorescent analysis of 4% paraformaldehyde-fixed Human Spleen tissue labeling EBI-3 with at 20 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red).](http://images.novusbio.com/fullsize/nbp1-76976_rabbit-polyclonal-ebi3-antibody-2711202420105819.jpg)
![Western Blot: EBI3 Antibody (5P10D3) [NBP2-03943] - Analysis using EBI3 antibody. Mouse EBI recombinant protein (A) and lysate from mouse kidney (B) probed with EBI3 antibody at 0.5 and 5 ug/ml, respectively. Goat anti-rat Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/EBI3-Antibody-5P10D3-Western-Blot-NBP2-03943-img0003.jpg "Western Blot: EBI3 Antibody (5P10D3) [NBP2-03943] - Analysis using EBI3 antibody. Mouse EBI recombinant protein (A) and lysate from mouse kidney (B) probed with EBI3 antibody at 0.5 and 5 ug/ml, respectively. Goat anti-rat Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.")
![Flow Cytometry: EBI3 Antibody (5P10D3) [NBP2-03943] - Intracellular flow cytometric analysis of mouse IL-35 in transfected and untransfected HEK 293 cells (Brefeldin A treated, 5 hours) using mouse EBI3 antibody at 2 ug/10^6 cells.](http://images.novusbio.com/fullsize/EBI3-Antibody-5P10D3-Flow-Cytometry-NBP2-03943-img0002.jpg)
![Western Blot: IL-27/IL-35 EBI3 Subunit Antibody (10J803) [NBP2-03940] - Analysis of mouse thymus tissue using EBI3 antibody at a concentration of 1 ug/ml.](http://images.novusbio.com/fullsize/IL-27-IL-35-EBI3-Subunit-Antibody-10J803-Western-Blot-NBP2-03940-img0007.jpg "Western Blot: IL-27/IL-35 EBI3 Subunit Antibody (10J803) [NBP2-03940] - Analysis of mouse thymus tissue using EBI3 antibody at a concentration of 1 ug/ml.")
![<b>Biological Strategies Validation. </b>Flow Cytometry: IL-27/IL-35 EBI3 Subunit Antibody (10J803) [NBP2-03940] - Figure A: Intracellular analysis of mouse IL-35 in transfected and untransfected HEK 293 cells (Brefeldin A treated, 5 hours) using mouse EBI3 antibody at 3 ug/10^6 cells. Figure B: Intracellular analysis of mouse EBI3 in stimulated and unstimulated RAW cells (LPS treated, 50 ng/ml, overnight) using mouse EBI3 antibody at 1.5 ug/10^6 cells.](http://images.novusbio.com/fullsize/IL-27-IL-35-EBI3-Subunit-Antibody-10J803-Flow-Cytometry-NBP2-03940-img0005.jpg)
![Western Blot: IL-27/IL-35 EBI3 Subunit Antibody (10J803) [NBP2-03940] - Western blot testing of mouse EBI3 monoclonal antibody at A) 0.1 ug/ml on recombinant protein and B) 3 ug/ml on recombinant mouse IL-35 protein. Goat anti-rat Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/IL-27-IL-35-EBI3-Subunit-Antibody-10J803-Western-Blot-NBP2-03940-img0006.jpg)
![Western Blot: IL-27/IL-35 EBI3 Subunit Antibody (42N1G4) [NBP2-27356] - Analysis using EBI3 antibody. Human EBI3 recombinant protein (A) and human IL-35 recombinant protein (B) probed with EBI3 antibody at 5 ug/ml. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/IL-27-IL-35-EBI3-Subunit-Antibody-42N1G4-Western-Blot-NBP2-27356-img0004.jpg "Western Blot: IL-27/IL-35 EBI3 Subunit Antibody (42N1G4) [NBP2-27356] - Analysis using EBI3 antibody. Human EBI3 recombinant protein (A) and human IL-35 recombinant protein (B) probed with EBI3 antibody at 5 ug/ml. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.")
![Flow Cytometry: IL-27/IL-35 EBI3 Subunit Antibody (42N1G4) [NBP2-27356] - Intracellular analysis of EBI3 in transfected cells using EBI3 antibody at 0.2 ug/10^6 cells.](http://images.novusbio.com/fullsize/IL-27-IL-35-EBI3-Subunit-Antibody-42N1G4-Flow-Cytometry-NBP2-27356-img0003.jpg)